Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses.
Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the leading authority on illicit drugs in the European Union.
Central Asia Drug Action Programme (CADAP Phase 6) represents continuity of the EU policy and long term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction. The beneficiaries of CADAP 6 include policy makers, drug experts, penitentiary and hospital staff, media professionals, teachers, drug users, prisoners, young people and the general public.
